Aurora and ethypharm reaffirm their commitment to promote access to medical cannabis for french patients

Nasdaq | tsx: acb edmonton, ab , may 30, 2023 /prnewswire/ - aurora europe gmbh, a subsidiary of aurora cannabis inc. (nasdaq: acb) (tsx: acb), and ethypharm are pleased to announce that they have once again been selected by the french general directorate of health (dgs) as exclusive suppliers of dried medical cannabis flower until the end of the french trial period. the trial has recently been extended until march 2024.
ACB Ratings Summary
ACB Quant Ranking